NASDAQ: ARTL
Artelo Biosciences Inc Stock Ownership - Who owns Artelo Biosciences?

Insider buying vs selling

Have Artelo Biosciences Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ARTL insiders and whales buy or sell their stock.

ARTL Shareholders

What type of owners hold Artelo Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Peter Michael Obrien26.11%345,000$1.22MInsider
Gregory D. Gorgas20.66%273,076$963.96kInsider
John Joseph Crawford7.24%95,671$337.72kInsider
Sharon M. Oster4.72%62,373$220.18kInsider
Connie Matsui4.29%56,667$200.03kInsider
Geode Capital Management LLC1.21%16,032$56.59kInstitution
Geneve Corp0.08%1,013$3.58kInsider
Tower Research Capital LLC Trc0.03%447$1.58kInstitution
Ubs Group Ag0.01%89$314.17Institution
Citigroup Inc0.00%9$31.77Institution

1 of 3

ARTL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ARTL1.26%63.09%
BGMS0.16%99.84%Net SellingNet Selling
GRI0.71%99.29%
CLDI15.34%84.66%Net BuyingNet Buying
GNPX11.63%88.37%Net Selling

Artelo Biosciences Stock Ownership FAQ

Who owns Artelo Biosciences?

Artelo Biosciences (NASDAQ: ARTL) is owned by 1.26% institutional shareholders, 63.09% Artelo Biosciences insiders, and 35.65% retail investors. Peter Michael Obrien is the largest individual Artelo Biosciences shareholder, owning 345,000.00 shares representing 26.11% of the company. Peter Michael Obrien's Artelo Biosciences shares are currently valued at $1.07M.

If you're new to stock investing, here's how to buy Artelo Biosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.